PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2023Theranostics69 citationsOpen Access

Hypoxia Induces M2 Macrophages to Express VSIG4 and Mediate Cardiac Fibrosis After Myocardial Infarction

YWYan WangYZYu ZhangJLJiao Li

Structured PICO

Does VSIG4 modulation alter scar formation and the myocardial inflammatory response in mouse models of acute myocardial infarction?

P
Population
Mouse models of acute myocardial infarction (VSIG4 knockout and adoptive bone marrow transfer chimeric models), as well as cultured cardiac fibroblasts and bone marrow M2 macrophages.
I
Intervention
VSIG4 knockout, adoptive bone marrow transfer, and gain- or loss-of-function experiments.
C
Comparator
Wild-type or control models.
O
Outcome
Scar formation, myocardial inflammatory response, and conversion of cardiac fibroblasts to myofibroblasts.surrogate

VSIG4 plays a crucial role in mediating cardiac fibrosis and tissue repair after acute myocardial infarction, presenting a potential immunomodulatory therapeutic target.

Abstract

M2 macrophage-mediated tissue repair plays an important role in acute myocardial infarction (AMI). Additionally, VSIG4, which is mainly expressed on tissue-resident and M2 macrophages, is crucial for the regulation of immune homeostasis; however, its effects on AMI remain unknown. In this study, we aimed to investigate the functional significance of VSIG4 in AMI using VSIG4 knockout and adoptive bone marrow transfer chimeric models. We also determined the function of cardiac fibroblasts (CFs) through gain- or loss-of-function experiments. We showed that VSIG4 promotes scar formation and orchestrates the myocardial inflammatory response after AMI, while also promoting TGF-β1 and IL-10. Moreover, we revealed that hypoxia promotes VSIG4 expression in cultured bone marrow M2 macrophages, ultimately leading to the conversion of CFs to myofibroblasts. Our results reveal a crucial role for VSIG4 in the process of AMI in mice and provide a potential immunomodulatory therapeutic avenue for fibrosis repair after AMI.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2023) studied this question.

synapsesocial.com/papers/69db8bcbf7e0c66ced835be4https://doi.org/10.7150/thno.78736
Ask AI
Helpful
Bookmark
Share
View Full Paper